Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19
Clinical trial NCT06197217 · COMPLETED
Trial details
- NCT number
- NCT06197217
- Sponsor
- Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-14
- Primary completion
- 2023-08-21
- Enrollment
- 1350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.